LT for PBC declined from 6.2% to 2.9%, while PSC remained stable. Yet post-LT survival is nearly identical. Villamil highlights divergent therapeutic progress and the unmet need in PSC.
This review covers best practices for first-line treatment of biliary strictures in PSC, emerging diagnostic approaches for cholangiocarcinoma, and strategies to minimize ERCP-related complications.